Arcellx, Inc. (ACLX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Arcellx, Inc. (ACLX)

Go deeper and ask any question about ACLX

Company Performance

Current Price

as of Oct 03, 2024

$76.20

P/E Ratio

N/A

Market Cap

$4.1B

Description

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.

Metrics

Overview

  • HQGaithersburg, MD
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerACLX
  • Price$76.2-0.04%

Trading Information

  • Market Cap$4.10B
  • Float75.08%
  • Average Daily Volume (1m)522,875
  • Average Daily Volume (3m)460,464
  • EPS-$1.08

Company

  • Revenue$144.75M
  • Rev Growth (1yr)91.47%
  • Net Income-$27.20M
  • Gross Margin95.48%
  • EBITDA Margin-123.26%
  • EBITDA-$33.75M
  • EV$2.51B
  • EV/Revenue17.35
  • P/EN/A
  • P/S28.17